Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) - U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish…
